Blood cancers, which include leukaemia, lymphoma and multiple myeloma, together account for a substantial share of new cancer diagnoses worldwide and their impact in India has grown steadily over the past decade. Blood cancer awareness month is observed every September, providing a dedicated period for clinicians, laboratories, patient advocacy groups, and public health bodies to focus attention on cancers that begin not in a single organ but in the blood-forming and lymphatic systems. Understanding what drives these cancers, how they are diagnosed and why this observance matters are relevant for families across every Indian city, from Ahmedabad and Surat to Kolkata and Hyderabad.
This article outlines the clinical background of blood cancers, the risk factors supported by current research, the laboratory tests used in diagnosis and monitoring, and the reason September National Blood Cancer Awareness Month continues to matter for public health.
What Month Is Blood Cancer Awareness Observed?
What month blood cancer awareness is marked each year is a frequent search query, and the answer is straightforward: September. The United States Congress designated September as National Blood Cancer Awareness Month in 2010, formally recognizing leukaemia, lymphoma, multiple myeloma and myelodysplastic syndromes under a single observance. When blood cancer awareness month is observed, it is closely related to this same designation, since the entire month, not a single day, is set aside for education, screening promotion, research support and relevant white papers.
Patient advocacy organizations, hospitals and laboratories in many countries have adopted September in the same spirit, and the phrase "World Blood Cancer Awareness Month" is now commonly used to describe this broader, internationally observed effort. Hospitals and diagnostic laboratories in India, too, increasingly frame their September campaigns under the world blood cancer awareness month banner to align with this wider global movement. Whether referred to nationally or globally, the underlying goal remains the same: correcting a persistent gap in public understanding of cancers that often produce vague, easily overlooked symptoms.
Understanding The Basics of Blood Cancers
Blood cancers develop when abnormal cells interfere with the normal production and function of blood cells. Unlike cancers that form a solid mass in one location, these cancers typically originate in the bone marrow or lymphatic tissue and can affect the entire body through the bloodstream. The three principal categories are as follows.
· Leukaemia is a cancer of the blood-forming cells, most often originating in the bone marrow and is classified as acute or chronic depending on how quickly it progresses.
· Lymphoma originates in the lymphatic system and is broadly divided into Hodgkin lymphoma and non-Hodgkin lymphoma, with non-Hodgkin lymphoma accounting for the larger share of cases.
· Multiple myeloma develops in plasma cells, a type of white blood cell responsible for antibody production and primarily affects the bone marrow.
A defining clinical feature shared across these cancers is that early symptoms are frequently mistaken for less serious conditions such as viral infections or general fatigue, which is precisely why Blood Cancer Awareness Month places such emphasis on recognizing patterns rather than waiting for a single definitive symptom.
Blood Cancer in India: A Rising Health Concern
According to the World Health Organization's International Agency for Research on Cancer, leukaemia accounted for an estimated 49,542 new cases in India, ranking eighth among all cancers and representing roughly 3.2 percent of the country's total cancer burden. Non-Hodgkin lymphoma accounted for an additional 41,973 new cases, ranking eleventh, while Hodgkin lymphoma contributed close to 9,973 cases. Together, these blood cancers represent a meaningful proportion of India's overall cancer incidence, underscoring why September National Blood Cancer Awareness Month deserves attention in Indian cities as much as anywhere else.
Diagnostic laboratories across Ahmedabad, Surat, Vadodara, Jaipur, Siliguri, Jamnagar, Indore, Srinagar, Kolkata, Mumbai and Hyderabad are witnessing steady growth in demand for blood-based diagnostic panels, reflecting both greater clinical awareness and the wider availability of laboratory testing in metropolitan as well as emerging urban centres.
Risk Factors for Blood Cancer
No single cause explains why one individual develops a blood cancer and another does not, but research has identified several well-established risk factors.
· Age: Risk generally rises with age, particularly for leukaemia and lymphoma subtypes that are more common in older adults, though certain leukaemia’s occur predominantly in children.
· Genetic and inherited conditions: Certain inherited disorders, including Down syndrome are associated with a higher risk of leukaemia.
· Prior cancer treatment: Previous chemotherapy or radiation therapy for another cancer can increase the likelihood of developing a blood cancer later in life.
· Chemical and radiation exposure: Long-term exposure to certain chemicals, such as benzene, and high-dose radiation exposure are recognized risk factors.
· Family history and immune status: A family history of blood cancer and conditions that weaken the immune system can also contribute to elevated risk.
None of these factors guarantees that a blood cancer will develop and many people diagnosed have no identifiable risk factor at all. This uncertainty is exactly why screening and prompt laboratory evaluation, rather than risk-factor assessment alone, form the backbone of early detection.
Signs and Symptoms to Watch For
Because early-stage blood cancers frequently produce vague or nonspecific symptoms, they are often overlooked until they are identified through routine blood work. When symptoms do appear, they commonly include the following.
· Persistent fatigue or weakness that does not improve with rest
· Recurring fevers or infections that are difficult to explain
· Easy bruising or unusual bleeding, including frequent nosebleeds
· Swollen lymph nodes in the neck, underarm, or groin
· Unexplained weight loss
· Night sweats and bone or joint pain
It is worth noting that several of these symptoms overlap considerably with common, non-cancerous conditions, which is precisely why laboratory testing, rather than symptoms alone, is required to distinguish between benign causes and an underlying blood cancer.
Blood Cancer Screening and Diagnosis: The Role of Laboratory Testing
Because blood cancers directly affect the composition of the blood, laboratory testing plays a central role in both initial detection and ongoing monitoring. Unipath Specialty Laboratory offers a range of blood-based diagnostic tests designed to support this process.
· The Complete Blood Count (CBC HO) test evaluates red blood cells, white blood cells, haemoglobin, platelets, and related indices and serves as the foundational screening tool when a blood cancer is suspected. It requires no fasting and typically delivers a same-day report. Details are available at the Unipath CBC test page.
· The Peripheral Smear Study examines the size, shape, and maturity of individual blood cells under a microscope, helping identify abnormal cell populations such as blasts that may indicate leukaemia. This test is also available with no fasting requirement and same-day reporting, and full details can be reviewed at the Unipath Peripheral Smear Study page.
· The beta-2 microglobulin (serum) test measures a protein whose elevated levels are associated with certain blood cancers, particularly multiple myeloma, and is frequently used to assess disease activity and monitor treatment response. Details are available at the Unipath Beta-2 Microglobulin test page.
All three tests are processed under NABL-accredited laboratory protocols, ensuring results that clinicians can rely on for diagnosis, staging, and treatment monitoring.
The Blood Cancer Awareness Month Ribbon and What It Represents
Readers often search for the blood cancer awareness month ribbon and its specific colour, and the honest answer is that there is no single universal ribbon for blood cancers as a group. The Leukaemia and Lymphoma Society uses red to represent blood cancers broadly, symbolizing blood itself, while individual blood cancer types are traditionally represented by their own colours: orange for leukaemia, a combination of lime green and violet for lymphoma, and burgundy for multiple myeloma.
This variation reflects the fact that blood cancer awareness month ribbon campaigns have evolved differently across patient organizations and countries over time. Regardless of the specific shade worn, the purpose remains consistent: prompting conversations about symptoms, risk factors, and the value of timely laboratory testing.
Why September National Blood Cancer Awareness Month Matters
This annual observance serves a function beyond calendar marking. It creates a recurring, predictable window during which hospitals, employers, and community organizations can coordinate screening drives, publish educational material, and reduce the delays that often accompany vague, easily dismissed symptoms.
In India specifically, limited public familiarity with blood cancers, compared with more widely discussed cancers, has historically delayed diagnosis. Campaigns built around blood cancer awareness month directly address this gap by normalizing conversations about persistent fatigue, unexplained bruising, and recurrent infections, encouraging people to seek a routine blood count rather than assuming these symptoms will resolve on their own.
When Should You Talk to a Doctor About Blood Testing?
There is no single screening age for blood cancers in the way there is for some solid tumours, since these cancers can affect people across a wide age range, including children. General guidance points to the following situations as reasons to consult a physician about laboratory testing.
· Symptoms lasting more than two to three weeks: Persistent fatigue, fevers, or infections that do not resolve within this window warrant clinical evaluation.
· A family history of blood cancer: Individuals with a first-degree relative diagnosed with leukaemia, lymphoma, or myeloma may benefit from an earlier conversation about baseline blood testing.
· Unexplained bruising, bleeding, or swollen lymph nodes: These findings, particularly in combination, should prompt a complete blood count and further clinical assessment.
· Monitoring after prior cancer treatment: Individuals previously treated with chemotherapy or radiation should discuss appropriate long-term blood monitoring with their physician.
These are starting points for a conversation with a physician rather than fixed rules, since individual risk profiles vary considerably. A physician will weigh symptoms, family history, and overall health before recommending a specific testing schedule. For those still searching for when blood cancer awareness month is, the answer remains the same every year: throughout September.
This annual observance exists precisely to prompt that first conversation. Individuals who have never discussed persistent, unexplained symptoms with their doctor are encouraged to use this observance as the occasion to do so.
Unipath Diagnostic Services: Serviceable Cities
Ahmedabad • Surat • Vadodara • Kolkata • Jaipur • Mumbai • Siliguri • Jamnagar
For test bookings and inquiries: Unipath
Disclaimer
Unipath does not represent or warrant that the content or information provided through our blog is accurate, complete, or current, nor that our blog content will be uninterrupted or error-free. We do not guarantee that any defects in our blog content will be corrected or that our server or the server hosting them is free of viruses or other harmful components. Unipath makes no warranties or representations regarding the use of materials in our blog content concerning their correctness, accuracy, adequacy, usefulness, timeliness, reliability, or otherwise, to the fullest extent permitted by applicable law. Information available via our platform and blog content may reference products, programs, or services not available in your region. You understand and acknowledge that your sole and exclusive remedy for any defect in or dissatisfaction with our blog content is to cease using them.
References and Citations
[1] World Health Organization, International Agency for Research on Cancer, GLOBOCAN India Fact Sheet,
[2] National Cancer Institute, Leukemia,
[3] American Cancer Society, Key Statistics for Leukemia,
[4] Mayo Clinic, Leukemia Symptoms and Causes,
[5] National Day Calendar, National Blood Cancer Awareness Month,
[6] Lymphoma Research Foundation, Blood Cancer Awareness Month,